Skip to main content

Meet the PulseData Team

  • IMG_2169
  • IMG_8153-1
  • IMG_2181
  • 20220610_133022

Meet our leadership

Committed to preventing costly decline from chronic disease and delivering what improves more people’s lives. 

Dean
Dean Panovich
Chief Executive Officer
Chris Kipers
Chris Kipers
Chief Technology Officer
Mari Headshot
Mari Mescolotto
Chief Marketing Officer
Bob Pirtle-1
Bob Pirtle
SVP Business Development
John Li
John Li
Head of Engineering
Paul Quindry
Paul Quindry
SVP Product

Who We Are

Hai Po Sun and Teddy Cha, the co-founders of PulseData, embarked on a mission to revolutionize the detection and understanding of chronic diseases. Their inspiration came from witnessing their own immediate family members endure the hardships of kidney failure, dialysis, and organ transplants, all of which could have been prevented. Motivated by this personal experience, they abandoned their previous careers in different industries and established pulseData, the sole AI healthcare company dedicated to identifying and predicting the progression of cardiorenal disease.

At PulseData, we provide in-depth insights into individuals' health conditions, offering valuable information that often goes unnoticed or undiagnosed. By partnering with us, healthcare professionals gain access to a clear and ongoing diagnosis of their patients, enabling them to proactively chart paths for improving lives and achieving positive outcomes. Our data and insights are delivered promptly, engineered to avert tragic, avoidable, and costly events on a large scale.

  • 100 million Americans are suffering from chronic comorbidities

  • Value based care, payers, providers, patients, and families attain better health outcomes with timely diagnosis and continuous data insights

  • PulseData is committed to preventing costly decline from chronic disease and delivering what improves more people’s lives

Meet the founders

Hai Po Sun
Hai Po Sun
Co-Founder
Teddy Cha-1
Teddy Cha
Co-Founder

Advisors

Meet PulseData's experienced advisors
Bryan Sivak

Bryan Sivak

Bryan Sivak has an extensive background in the healthcare industry, having held key positions in prominent organizations. He formerly served as the Senior Vice President of Technology, Innovation, and Modernization at Centene Corporation. Prior to that, he excelled as the Managing Director of Kaiser Permanente Ventures and as the Vice President of Medicaid Transformation at Kaiser Permanente.

Ned Carlson

Ned Carlson

Ned Carlson is a highly accomplished healthcare executive who has made significant contributions to the field throughout his career. With a successful tenure as the Chief Executive Officer of Trumpet Behavioral Health, Ned Carlson played a pivotal role in advancing the organization's mission of providing exceptional behavioral health services.

Isaac Kohane, MD, PhD

Isaac Kohane, MD, PhD

Dr. Isaac Kohane, MD, PhD, is an esteemed figure in the field of healthcare and biomedical informatics, renowned for his significant contributions and leadership roles within prestigious institutions. As the Marion V. Nelson Professor of Biomedical Informatics at Harvard Medical School, Dr. Kohane holds a distinguished position that reflects his expertise and commitment to advancing the intersection of medicine and technology.

As a leading authority in the field, Dr. Isaac Kohane continues to shape the future of healthcare through his groundbreaking research, influential leadership positions, and unwavering dedication to improving patient care through the power of informatics and technology.

Dr. Navdeep Tangri, MD, PhD, FRCPC

Dr. Navdeep Tangri, MD, PhD, FRCPC

Dr. Navdeep Tangri, MD, PhD, FRCPC, is a highly regarded expert in the field of nephrology and a distinguished figure in the Canadian medical community. As an associate professor in the nephrology division at the University of Manitoba, Dr. Tangri has made significant contributions to the understanding and management of chronic kidney disease (CKD).

One of Dr. Tangri's most notable achievements is his pioneering research in developing a predictive model for the progression of CKD to kidney failure. This model, known as the Kidney Failure Risk Equation (KFRE), has revolutionized the field by providing clinicians with a valuable tool to assess and predict the risk of CKD progression in individual patients.